Regulator may make pharma inspections public as it steps up scrutiny
The CDSCO, along with state drugs controllers (SDCs), conducted risk-based inspections of over 960 premises across the country since December, 2022; and based on these findings, more than 860 actions including issuance of show cause notices, stop production order, suspension, cancellation of licences/product licenses, and warning letters have been issued, according to Union minister of state for health Anupriya Patel in Lok Sabha on 27 March.
Post Comment